ZMUni Compliance Centre

  At the opening meeting of the 14th National People's Congress (NPC), Chinese Premier Li Qiang emphasized China's commitment to accelerating the development of new productive forces and promoting the growth of the bioeconomy. In response, local governments have implemented policies to encourage regional advancements in synthetic biology, positioning the industry for continued expansion and innovation.   Owing to strong government backing and growing market interest, China's synthetic biology industry has seen significant growth in recent years. By the end of August 2024, the industry had completed 44 financing rounds in China, raising over 2 billion RMB, reflecting the industry's accelerating momentum.  

  | Peptides Surge in Popularity    In recent years, peptides have gained significant momentum in the anti-aging sector in China, emerging as a key ingredient alongside renowned components like retinol, pro-xylane, and collagen.   As of the end of September 2024, there were 21,665 skincare products featuring peptides as their primary selling point that are active in China, with the majority of them registered/notified in the past two years. According to data from Frost & Sullivan, the market size for peptide-based cosmetic ingredients in China reached RMB 1.45 billion in 2021 and is projected to grow to RMB 2.32 billion by 2025, reflecting

   On September 13, 2024, the National Medical Products Administration (NMPA) of China issued a public notice revealing that a Spanish cosmetic company is suspected of using the prohibited ingredient "Diflorasone Propionate" in its products. To Ensure Public Safety in Cosmetic Use, China NMPA has ordered a suspension of sales of the company’s implicated products in China.   The misuse of prohibited and restricted cosmetic ingredients is a common violation in China. These practices pose significant risks to consumer health and undermine market integrity. In response, regulatory authorities are continuously tightening enforcement measures to ensure compliance and uphold product safety

  In the first half of 2024, Chinese cosmetic ingredient enterprises demonstrated steady and impressive performance, in contrast to the significant fluctuations seen by international giants. Despite an overall sluggish consumer market, leading personal care and ingredient enterprises maintained solid growth momentum.    In the competitive Chinese cosmetic ingredient market, recombinant collagen has emerged as a standout ingredient. In terms of ingredient types, plant-based and chemical ingredients are now on equal footing. Chinese companies are increasingly exploring China’s unique plant resources, leveraging differentiation strategies to unlock the potential of plant extracts and establish strong product barriers.   So far, Chinese cosmetic ingredients enterprises have

  Pet Economy Boom in China    In recent years, China's "pet economy" has seen rapid growth, fueled by expanding consumer demand and investment.   According to the 2023-2024 China Pet Industry White Paper, the number of pet dogs reached 51.75 million in 2023, up 1.1% from 2022, while pet cats grew to 69.8 million, a 6.8% increase. This steady rise in pet ownership reflects the growing potential of China’s pet market, offering significant opportunities for future growth.   Year Dog (million) Cat (million) 2020 52.22 48.62 2021 54.29 58.06 2022 51.19 65.36 2023 51.75 69.80 Table 1: Changes in Dog

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.        In the previous episodes, we covered the key highlights of the Animal Testing Alternatives in China and NCI with a focus on the History of Safe Use section from the webinar.   Today, we'll wrap up with the final section, highlighting NCI of polymers and important points to note for NCI applications, as presented in the webinar.     | Polymers

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.       This webinar focused on the following five key parts:   1.Background: Get Ready for China’s NCI Regulatory Regime 2.China to Accept Animal-alternative Test Data under Specific Conditions 3.Understanding the Application under Situation 3 and 5, NCI with HoSU 4.Understanding the Application under Situation 6, NCI of Polymer 5.Points to Note for NCI Application in China   The

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.   This webinar focused on the following five key parts:   1.Background: Get Ready for China’s NCI Regulatory Regime 2.China to Accept Animal-alternative Test Data under Specific Conditions 3.Understanding the Application under Situation 3 and 5, NCI with HoSU 4.Understanding the Application under Situation 6, NCI of Polymer 5.Points to Note for NCI Application in China   The following is